Crossmark

Risk-Based Comparability Assessment for Monoclonal Antibodies During Drug Development: A Clinical Pharmacology Perspective

Crossref DOI link: https://doi.org/10.1208/s12248-018-0268-8

Published Online: 2018-10-15

Published Print: 2018-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhuang, Yanli

Chen, Di

Sharma, Amarnath

Xu, Zhenhua
License Information

Text and Data Mining valid from 2018-10-15
More Information

Article History

Received: 6 August 2018

Accepted: 19 September 2018

First Online: 15 October 2018

Compliance with Ethical Standards

:

: YZ, DC, AS, and ZX are employees of Janssen Research & Development, LLC and hold stock in Johnson & Johnson.